Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
November 21, 2019 22:04 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
November 19, 2019 16:01 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Third Quarter and Nine Months of 2019 Financial Results
November 12, 2019 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Latest Advanced Wound Care Research from Organogenesis Highlighted at SAWC Fall 2019
October 11, 2019 16:05 ET
|
Organogenesis Holdings Inc.
CANTON, Mass. and LAS VEGAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
New ReNu® Data from Organogenesis Highlighted at ICRS 2019 World Congress
October 05, 2019 09:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass. and VANCOUVER, British Columbia, Oct. 05, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development,...
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019
September 17, 2019 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
MEDIA ALERT: Organogenesis Holdings Inc. (Nasdaq: ORGO) to Ring the Nasdaq Stock Market Closing Bell
September 06, 2019 09:00 ET
|
Organogenesis Holdings Inc.
NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- What:Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company, will visit the Nasdaq MarketSite in Times Square. In honor...
Organogenesis Announces Annual College Scholarship Award Winner
September 06, 2019 08:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 06, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants
August 19, 2019 16:57 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company”) announced today the completion of its previously announced exchange offer (the “Offer”)...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2019 Financial Results
August 09, 2019 07:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...